Cost-effectiveness of screening programs for Chlamydia trachomatis: A population-based dynamic approach

Sexually Transmitted Diseases

Volumn 27, Issue 9, 2000, Pages 518-529

  Welte, Robert ^a,b   Kretzschmar, Mirjam ^a   Leidl, Reiner ^b   Van Den Hoek, Anneke ^c   Jager, Johannes C ^a   Postma, Maarten J ^d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF ULM   (Germany)

^c MUNICIPAL HEALTH SERVICE   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; FEMALE; GENERAL PRACTITIONER; HETEROSEXUALITY; HUMAN; INCIDENCE; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; SCREENING; SEXUAL BEHAVIOR; STOCHASTIC MODEL; URINALYSIS;

EID: 0033778672     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200010000-00005     Document Type: Article

References (59)

1. Global prevalence and incidence estimates of selected curable STDs
2. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States: American Social Health Association
3. Recommendations for the prevention and management of Chlamydia trachomatis infections
4. New opportunities for chlamydia prevention: Application of science to public health practice
5. Screening for chlamydial infection, including ocular prophylaxis in newborns
6. Chlamydia trachomatis genital infections: United States, 1995
7. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: Declining rates for how much longer?
8. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program
9. Should asymptomatic patients be tested for Chlamydia trachomatis in the general practice?
10. An economic evaluation of screening for Chlamydia trachomatis in adolescent males
11. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women
12. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: A cost-effectiveness analysis of three strategies
13. Screening women for Chlamydia trachomatis in family planning clinics: The cost-effectiveness of DNA amplifications assays
14. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women
15. Control of Chlamydia trachomatis infections in female army recruits: Cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease
16. Screening for Chlamydia trachomatis in adolescent males: A cost based decision analysis
17. Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de seksueel actieve bevolking in Amsterdam I: Meer dan 90% deelname en bijna 5% prevalentie
18. Azithromycin: A pharmaeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogential Chlamydia trachomatis infections in women
19. A comparative model-based analysis of screening programs for Chlamydia trachomatis infections
20. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: Implications for diagnostic testing and screening
21. Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction
22. Comparison of the ligase chain reaction with cell culture for diagnosis of Chlamydia trachomatis in women
23. Partner referral by patients with gonorrhea and chlamydial infection
24. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships
25. Asymptomatic Chlamydia trachomatis urethritis in men
26. Genital chlamydial infections: Epidemiology and reproductive sequelae
27. Control of chlamydia: A role for every clinician who sees sexually active patients
28. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: An epidemiologic update
29. Pelvic inflammatory disease: Guidelines for prevention and management
30. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries
31. Pelvic inflammatory disease and fertility: A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results
32. Prospective study of perinatal transmission of Chlamydia trachomatis
33. Prospective study of maternal and infertile infection with Chlamydia trachomatis
34. Chlamydia trachomatis infections in the United States: What are they costing us?
35. Reporting format for economic evaluation. Part II: Focus on modelling studies
36. 1998 Guidelines for treatment of sexually transmitted diseases
37. The economic cost of pelvic inflammatory disease
38. Chlamydia trachomatis infections: United States, 1995
39. Pooling of urine specimens for PCR testing: A cost saving strategy for Chlamydia trachomatis control programmes
40. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women
41. Epidemiology of genital chlamydial infections in patients with chlamydial conjunctivitis: A retrospective study
42. The impact of antimicrobial resistance on the treatment of sexually transmitted diseases
43. Selective screening for Chlamydia trachomatis in a primary care population of women
44. Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations